Celltrion | 068270 - Loan Capital

Stock Price
204,000.00
Daily Change
-3,000.00 -1.45%
Monthly
1.24%
Yearly
26.47%
Q2 Forecast
197,024.30

Celltrion reported KRW63.29B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Celltrion KRW 63.29B 4.01B Sep/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Moderna USD 610M 584M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025